Entrada Therapeutics Inc. (TRDA)

AI Score

Unlock

8.97

0.26 (2.99%)

At close: Apr 24, 2025, 3:59 PM

9.34

4.12%

After-hours: Apr 24, 2025, 04:34 PM EDT

Entrada Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	101.21M	78.05M	185.25M	68.44M	67.6M	51.88M	376.79M	227.65M	45.16M	53.31M	90.87M	84.64M	291.06M	122.17M	136.95M	n/a	39.05M	n/a
Short-Term Investments	318.79M	371.3M	284.49M	258.98M	284.37M	301.7M	297.05M	183.98M	143.56M	162.26M	153.39M	179.26M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	3.95M	3.95M	3.95M	3.95M	3.95M	3.95M	3.95M	3.95M	3.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.23M	4.7M	747K	2.76M	2.79M	2.98M	538K	13.84M	5.21M	954K	875K	5.38M	872K	2.97M	791K	-39.05M	541K	-16.84M
Receivables	3.68M	2.6M	n/a	77.51M	n/a	5.03M	3.74M	6.3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	1.00	1.00	-5.03M	n/a	183.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	16.36M	13.39M	19.79M	9.24M	17.8M	1.6M	9.66M	16.21M	21.16M	19.16M	9.65M	8.81M	n/a	1.35M	n/a	n/a	n/a	n/a
Total Current Assets	440.04M	465.33M	489.54M	414.17M	369.77M	383.04M	390.19M	434.13M	209.88M	234.73M	253.9M	272.71M	298.7M	123.53M	137.64M	39.05M	39.95M	16.84M
Property-Plant & Equipment	82.05M	84.56M	87.73M	89.96M	92.68M	95.06M	99.3M	23.64M	33.02M	34.83M	37.19M	38.61M	6.26M	5.9M	5.09M	n/a	3.04M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	86.28M	89.25M	92.43M	96.67M	99.42M	101.99M	103.79M	41.43M	42.18M	39.73M	42.01M	43.99M	7.13M	8.87M	5.88M	-39.05M	3.58M	-16.84M
Total Assets	526.32M	554.59M	581.96M	510.84M	469.19M	485.03M	493.98M	475.57M	252.06M	274.46M	295.92M	316.7M	305.83M	132.4M	143.51M	n/a	43.53M	n/a
Account Payables	4.26M	1.29M	1.64M	2.53M	3.28M	752K	2.42M	6.47M	5.99M	1.34M	4.62M	2.93M	706K	2.28M	1.88M	n/a	1.6M	n/a
Deferred Revenue	13.65M	45.92M	60.5M	148.46M	132.26M	148.44M	101.64M	122.34M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	7.74M	8.57M	n/a	7.91M	6.64M	7.41M	7.1M	n/a	8.26M	8.11M	7.97M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	8.43M	-182K	2.96M	5.75M	3.78M	-564K	4.31M	-1.03M	431K	-341K	-5.13M	-5.08M	485K	823K	413K	n/a	115K	n/a
Total Current Liabilities	39.48M	70.6M	85.81M	173.94M	158.8M	165.43M	125.94M	147.59M	21.97M	21.55M	18.08M	15.43M	6.72M	7.16M	4.54M	n/a	3.36M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	396K	197.83M	197.99M	-40.17M	81.66M	-16.3M
Total Long-Term Liabilities	58.16M	61.54M	66.23M	67.54M	68.04M	72.94M	161.13M	98.36M	17.53M	19.69M	21.8M	23.89M	396K	197.83M	197.99M	-40.17M	81.66M	-16.3M
Total Liabilities	97.64M	132.14M	152.04M	241.48M	226.83M	238.37M	287.07M	245.96M	39.5M	41.24M	39.88M	39.31M	7.12M	204.99M	202.53M	-40.17M	85.02M	-16.3M
Total Debt	59.21M	61.31M	64.44M	66.43M	68.23M	69.07M	73.03M	16.23M	25.94M	27.95M	29.91M	31.86M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	4K	4K	4K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-129.34M	-130.47M	-116.44M	-171.47M	-194.97M	-185.43M	-220.89M	-194.96M	-188.28M	-163.66M	-138.52M	-115.34M	-93.67M	-75.22M	-60.79M	n/a	-42.51M	n/a
Comprehensive Income	-43K	972K	-329K	-246K	195K	-496K	-1M	-642K	-2.06M	-2.75M	-2.27M	-1.53M	n/a	n/a	n/a	-41.49M	n/a	-15.52M
Shareholders Equity	428.68M	422.45M	429.93M	269.37M	242.36M	246.66M	206.91M	229.61M	212.55M	233.22M	256.04M	277.39M	298.72M	-72.59M	-59.01M	40.17M	-41.49M	16.3M
Total Investments	318.79M	371.3M	288.44M	262.93M	288.32M	301.7M	297.05M	183.98M	143.56M	162.26M	153.39M	179.26M	n/a	n/a	n/a	n/a	n/a	n/a